Journals / Van Tıp Dergisi / 2022 / Cilt: 29 - Sayı: 3

Relationship between Non-Alcoholic Fatty Liver Disease and Cardiovascular and Metabolic Risk Indices

Non Alkolik Yağlı Karaciğer Hastalığının Kardiyovasküler ve Metabolik Risk İndeksleri ile İlişkisi

Pages
275–282
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: Between individuals with and without NAFLD there were statistically significant differences in terms of waist circumference (WC), waist-hip ratio (WHR), body mass index (BMI), ALT, AST/ALT, uric acid, smoking status, lipid levels, Triglyceride/HDL, hemoglobin, homeostasis model assessment insulin resistance (HOMA-IR), triglyceride-glucose index (TyG), visceral adiposity index (VAI) parameters (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: While non-alcoholic fatty liver disease (NAFLD) is linked to other metabolic dysfunction, it may also occur alone.
📊
Key Findings & Data:Materials and Methods: The files of the patients that applied to our check-up outpatient clinic were evaluated retrospectively, and patients who met the criteria for admission to the study were divided into those with and without NAFLD (n=277 and n=280, respectively) with the age variable being adjusted.
💡
Conclusion & Impact:Results: Between individuals with and without NAFLD there were statistically significant differences in terms of waist circumference (WC), waist-hip ratio (WHR), body mass index (BMI), ALT, AST/ALT, uric acid, smoking status, lipid levels, Triglyceride/HDL, hemoglobin, homeostasis model assessment insulin resistance (HOMA-IR), triglyceride-glucose index (TyG), visceral adiposity index (VAI) parameters (p
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: While non-alcoholic fatty liver disease (NAFLD) is linked to other metabolic dysfunction, it may also occur alone. In our study, we investigate the factors associated with NAFLD in subjects that do not have metabolic syndrome. Materials and Methods: The files of the patients that applied to our check-up outpatient clinic were evaluated retrospectively, and patients who met the criteria for admission to the study were divided into those with and without NAFLD (n=277 and n=280, respectively) with the age variable being adjusted. Anthropometric and biochemical values, fibrosis scores, cardiovascular and metabolic risk indices were compared between groups. Results: Between individuals with and without NAFLD there were statistically significant differences in terms of waist circumference (WC), waist-hip ratio (WHR), body mass index (BMI), ALT, AST/ALT, uric acid, smoking status, lipid levels, Triglyceride/HDL, hemoglobin, homeostasis model assessment insulin resistance (HOMA-IR), triglyceride-glucose index (TyG), visceral adiposity index (VAI) parameters (p

Özet

Amaç: Non alkolik yağlı karaciğer hastalığının (NAYKH) diğer metabolik disfonksiyonlarla birlikteliği oldukça fazla olmasına rağmen tek başına da karşımıza çıkabilmektedir. Çalışmamızda metabolik sendromu olmayan hastalarda NAYKH ile ilişkili faktörleri araştırmayı amaçladık. Gereç ve Yöntem: Check-up polikliniğimize başvurmuş hastaların dosyaları retrospektif olarak taranarak, çalışmaya alınma kriterlerine uyan hastalar yaş değişkeni eşitlenerek 277 NAYKH olan ve 280 olmayan kişi olarak iki gruba ayrıldı. Gruplar arası antropometrik ve biyokimyasal değerler, fibrozis skorları, kardiyovasküler ve metabolik risk indeksleri karşılaştırıldı. Bulgular: Yağlı karaciğeri olan ve olmayan bireyler arasında bel çevresi, bel kalça oranı (BKO), vücut kitle indeksi (VKİ), ALT, AST/ALT oranı, ürik asit, sigara içme durumları, lipid düzeyleri, Trigliserit/HDL oranı, hemoglobin, homeostaz modeli insülin direnci değerlendirmesi (HOMA-IR), trigliserit-glukoz indeksi (TyG), visseral adipozite indeksi (VAI) parametreleri açısından istatistiksel olarak anlamlı farklılıklar vardı (p

🔖

Cite This Article

DEMİR, S., ŞUBAŞI, H. E. (2022). Relationship between Non-Alcoholic Fatty Liver Disease and Cardiovascular and Metabolic Risk Indices. Van Tıp Dergisi, Cilt: 29 - Sayı: 3, 275–282. https://ajindex.com/articles/645896

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease- meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016; 64(1): 73-84
  2. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994; 107: 1103-1109
  3. Gaggini M, Morelli M, Buzzigoli E, DeFronzo RA, Bugianesi E, Gastaldelli A. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients 2013; 5(5): 1544- 1560
  4. Eslam M. Sanyal AJ, George J. MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology 2020; 158(7): 1999-2014
  5. Mashek DG. Hepatic lipid droplets: a balancing act between energy storage and metabolic dysfunction in NAFLD. Mol Metab 2021; 50: 101115
  6. Charatcharoenwitthaya P, Lindor KD. Role of radiologic modalities in the management of non-alcoholic steatohepatitis. Clin Liver Dis 2007; 11(1): 37-54
  7. İdilman İS, Karçaaltıncaba M. Karaciğer yağlanması tanısında ve yağlanma miktarının belirlenmesinde radyolojik tanı yöntemleri. Güncel Gastroenteroloji 2014; 18(1): 112- 118
  8. Sassoa M, Miettea V, Sandrina L, Beaugrand M. The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan®. Clin Res Hepatol Gas 2012; 36(1): 13-20
  9. Biberci Keskin E, Coban G. Evaluation of liver biopsy findings and comparison with noninvasive fibrosis scores in patients with non-alcoholic steatohepatitis. Medeniyet Med J 2019; 34(4): 354-359
  10. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999; 30(6): 1356-1362
  11. Amato MC, Giordan C, Massimo G, Criscimanna A, Vitabile S, Midiri M, et al. Visceral adiposity index a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care 2010; 33(4): 920-922
  12. Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat D 2008; 6(4): 299-304
  13. Marotta T, Russo BF, Ferrara LA. Triglyceride-to-HDL-cholesterol ratio and metabolic syndrome as contributors to cardiovascular risk in overweight patients. Obesity 2010; 18(8): 160